Evaluation of Seropositivity After Standard Doses of Vaccination Against SARS-CoV-2 in Patients With Early Breast Cancer Receiving Adjuvant Treatment

BACKGROUND: Coronavirus disease 2019 (COVID-19) pandemic affected millions of individuals, and patients with cancer are known to be more susceptible. Vaccines against SARS-CoV-2 have been developed and used for patients with cancer, but scarce data are available on their efficacy in patients under a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jinyong, Chang, Euijin, Park, Song Yi, Lee, Dae-Won, Kang, Chang Kyung, Choe, Pyoeng Gyun, Kim, Nam Joong, Oh, Myoung-don, Park, Wan Beom, Lee, Kyung-Hun, Im, Seock-Ah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Breast Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732225/
https://www.ncbi.nlm.nih.gov/pubmed/36218350
http://dx.doi.org/10.1093/oncolo/oyac196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732225/
https://www.ncbi.nlm.nih.gov/pubmed/36218350
http://dx.doi.org/10.1093/oncolo/oyac196

Ejemplares similares